| Cell line name | PFIZi024-A |
|---|---|
| Synonyms | B218c6 |
| Accession | CVCL_RG01 |
| Resource Identification Initiative | To cite this cell line use: PFIZi024-A (RRID:CVCL_RG01) |
| Comments | From: Pfizer, Inc.; New York; USA. Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178. |
| Sequence variations |
|
| Disease | Developmental and epileptic encephalopathy 19 (NCIt: C142802) Non-specific early-onset epileptic encephalopathy (ORDO: Orphanet_442835) |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Sex of cell | Male |
| Age at sampling | 30-34Y |
| Category | Induced pluripotent stem cell |
| Cross-references | |
| Cell line collections (Providers) | EBiSC; PFIZi024-A
ECACC; 66540609 - Discontinued |
| Cell line databases/resources | hPSCreg; PFIZi024-A |
| Biological sample resources | BioSamples; SAMEA104236754 |
| Encyclopedic resources | Wikidata; Q54947279 |
| Entry history | |
| Entry creation | 05-Mar-2018 |
| Last entry update | 30-Jan-2024 |
| Version number | 10 |